Status:
COMPLETED
Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort
Lead Sponsor:
University of Ulsan
Collaborating Sponsors:
Ulsan University Hospital
Conditions:
Tuberculosis
Tuberculosis, Pulmonary
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective cohort study. The purpose of this study is to investigate clinical features of the patients with the cavitary pulmonary tuberculosis (TB) and endobronchial TB from the pa...
Detailed Description
Cavitary pulmonary tuberculosis (TB) is known to remain its Infectivity for a longer period of time than the non-cavitary pulmonary TB, which is usually almost inactivated its infectivity within two w...
Eligibility Criteria
Inclusion
- A. Cavitary Pulmonary TB Group
- Aged 18 years and older
- The patient who has the cavitary pulmonary TB
Exclusion
- Age \< 18 years
- Any Malignant patient
- Patients with bacterial or viral or fungal pneumonia based on the judgment of the attending physician
- Patients who had a history of any pulmonary cystic lesion such as infected bulla, bullous emphysema
- Patients who were diagnosed with pulmonary fungal infection or previous its history or any documented culture of the fungus from a bronchial sample including sputum
- Patients who were diagnosed with bronchiectasis
- Patients who were diagnosed with NTM-PD (non-tuberculous mycobacterial pulmonary disease) or any documented culture of NTM from a bronchial sample including sputum
- Patients who were diagnosed with connective tissue disease such as Wegener's granulomatosis, SLE
- Patients who were diagnosed with TB destroyed lung
- Patients who were diagnosed with congenital lung disease such as Congenital Cystic Adenomatoid Malformation (CCAM), pulmonary sequestration
- Patients who were diagnosed with interstitial lung disease such as Lymphangioleiomyomatosis (LAM), idiopathic pulmonary fibrosis (IPF)
- Patients who were diagnosed with culture-negative pulmonary TB
- Patients who did not take anti-TB medication more than twice a week on average
- Patients who were diagnosed with sarcoidosis
- Patients who were diagnosed with paragonimiasis
- Patients who were diagnosed with pulmonary thromboembolism due to excluding pulmonary infarction
- The patient who did not consent
- Patients who were diagnosed with MDR/XDR TB through AFB culture
- B. Endobronchial TB Group
- Inclusion Criteria:
- Aged 18 years and older
- The patient who has the endobronchial TB through bronchoscopy
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03822156
Start Date
January 1 2010
End Date
June 30 2018
Last Update
June 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulsan University Hospital, 877 Bangeojin Sunwhando-ro
Ulsan, South Korea, 44033